Sfoglia per AUTORE
DOGLIOTTI L
Collezione AOU San Luigi di Orbassano

  

Items : 61

Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2011 Jun;20(5):683-90. doi: 10.1007/s11136-010-9795-1. Epub 2010 Nov 16.
2011
AOU San Luigi di Orbassano

Saini A; Berruti A; Capogna S; Negro M; Sguazzotti E; Picci RL; Campagna S; Dongiovanni V; Dogliotti L; Furlan PM; Ostacoli L;

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Apr;22(4):988-990. doi: 10.1093/annonc/mdr010. Epub 2011 Feb 14.
2011
AOU San Luigi di Orbassano

Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A;

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. in The oncologist / Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11.
2011
AOU San Luigi di Orbassano

Buttigliero C; Monagheddu C; Petroni P; Saini A; Dogliotti L; Ciccone G; Berruti A;

2011
AOU San Luigi di Orbassano

Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; et alii...

Intermediate endpoints of primary systemic therapy in breast cancer patients. in Journal of the National Cancer Institute. Monographs / J Natl Cancer Inst Monogr. 2011;2011(43):142-6. doi: 10.1093/jncimonographs/lgr036.
2011
AOU San Luigi di Orbassano

Berruti A; Generali D; Bertaglia V; Brizzi MP; Mele T; Dogliotti L; Bruzzi P; Bottini A;

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2010 Oct;123(3):795-804. doi: 10.1007/s10549-010-1063-0. Epub 2010 Aug 3.
2010
AOU San Luigi di Orbassano

Mele T; Generali D; Fox S; Brizzi MP; Bersiga A; Milani M; Allevi G; Bonardi S; Aguggini S; Volante M; Dogliotti L; Bottini A; Harris A; Berruti A;

Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2010 May;19(4):531-7. doi: 10.1007/s11136-010-9614-8. Epub 2010 Feb 27.
2010
AOU San Luigi di Orbassano

Ostacoli L; Saini A; Ferini-Strambi L; Castronovo V; Sguazzotti E; Picci RL; Toje M; Gorzegno G; Capogna S; Dongiovanni V; Dogliotti L; Furlan PM; Berruti A;

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. in Open access journal of urology / Open Access J Urol. 2010 Jul 23;2:109-24. doi: 10.2147/rru.s6573.
2010
AOU San Luigi di Orbassano

Berruti A; Vignani F; Russo L; Bertaglia V; Tullio M; Tucci M; Poggio M; Dogliotti L;

2009
AOU San Luigi di Orbassano

Brizzi MP; Berruti A; Ferrero A; Milanesi E; Volante M; Castiglione F; Birocco N; Bombaci S; Perroni D; Ferretti B; Alabiso O; Ciuffreda L; Bertetto O; Papotti M; Dogliotti L;

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.
2009
AOU San Luigi di Orbassano

Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A;

2008
AOU San Luigi di Orbassano

Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;

Emerging drugs for adrenocortical carcinoma. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2008 Sep;13(3):497-509. doi: 10.1517/14728214.13.3.497.
2008
AOU San Luigi di Orbassano

Berruti A; Ferrero A; Sperone P; Daffara F; Reimondo G; Papotti M; Dogliotti L; Angeli A; Terzolo M;

Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions. in The oncologist / Oncologist. 2008 Nov;13(11):1137-48. doi: 10.1634/theoncologist.2008-0162. Epub 2008 Nov 7.
2008
AOU San Luigi di Orbassano

Berruti A; Brizzi MP; Generali D; Ardine M; Dogliotti L; Bruzzi P; Bottini A;

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. in Endocrine-related cancer / Endocr Relat Cancer. 2008 Dec;15(4):1043-53. doi: 10.1677/ERC-08-0103. Epub 2008 Sep 29.
2008
AOU San Luigi di Orbassano

Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M;

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. in The Journal of urology / J Urol. 2007 Sep;178(3 Pt 1):838-43; quiz 1129. doi: 10.1016/j.juro.2007.05.018. Epub 2007 Jul 16.
2007
AOU San Luigi di Orbassano

Berruti A; Mosca A; Porpiglia F; Bollito E; Tucci M; Vana F; Cracco C; Torta M; Russo L; Cappia S; Saini A; Angeli A; Papotti M; Scarpa RM; Dogliotti L;

Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy. in Journal of cancer research and clinical oncology / J Cancer Res Clin Oncol. 2007 Oct;133(10):783-5. doi: 10.1007/s00432-007-0234-9. Epub 2007 Jun 6.
2007
AOU San Luigi di Orbassano

Tampellini M; Brizzi MP; Bitossi R; Alabiso I; Sculli CM; Chiusa L; Papotti M; Dogliotti L;

Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2007 Nov;20(11):1172-82. doi: 10.1038/modpathol.3800954. Epub 2007 Sep 14.
2007
AOU San Luigi di Orbassano

Volante M; Brizzi MP; Faggiano A; La Rosa S; Rapa I; Ferrero A; Mansueto G; Righi L; Garancini S; Capella C; De Rosa G; Dogliotti L; Colao A; Papotti M;

2007
AOU San Luigi di Orbassano

Dogliotti L; Mosca A;

Co-expression of EGF receptor, TGFalpha and S6 kinase is significantly associated with colorectal carcinomas with distant metastases at diagnosis. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2007 Mar;450(3):321-8. doi: 10.1007/s00428-007-0370-2. Epub 2007 Jan 30.
2007
AOU San Luigi di Orbassano

Tampellini M; Longo M; Cappia S; Bacillo E; Alabiso I; Volante M; Dogliotti L; Papotti M;

2007
AOU San Luigi di Orbassano

Dogliotti L; Cartenì G; Siena S; Bertetto O; Martoni A; Bono A; Amadori D; Onat H; Marini L;

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. in Journal of endocrinological investigation / J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148.
2006
AOU San Luigi di Orbassano

Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L;

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.
2006
AOU San Luigi di Orbassano

Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.
2006
AOU San Luigi di Orbassano

Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.
2006
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;

Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2006 Aug;18(4):433-6. doi: 10.1179/joc.2006.18.4.433.
2006
AOU San Luigi di Orbassano

Tampellini M; Alabiso I; Sculli CM; Barberis M; Giachino D; Berruti A; Dogliotti L;

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. in British journal of cancer / Br J Cancer. 2005 Sep 19;93(6):633-8. doi: 10.1038/sj.bjc.6602767.
2005
AOU San Luigi di Orbassano

Berruti A; Tucci M; Mosca A; Tarabuzzi R; Gorzegno G; Terrone C; Vana F; Lamanna G; Tampellini M; Porpiglia F; Angeli A; Scarpa RM; Dogliotti L;

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. in Endocrine-related cancer / Endocr Relat Cancer. 2005 Sep;12(3):657-66. doi: 10.1677/erc.1.01025.
2005
AOU San Luigi di Orbassano

Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L;

Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2005 Oct;16(10):1662-6. doi: 10.1093/annonc/mdi314. Epub 2005 Jul 8.
2005
AOU San Luigi di Orbassano

Novello S; Fava C; Borasio P; Dogliotti L; Cortese G; Crida B; Selvaggi G; Lausi P; Brizzi MP; Sperone P; Cardinale L; Ferraris F; Perotto F; Priola A; Scagliotti GV;

Low dose CT in early lung cancer diagnosis: Prevalence data. in La Radiologia medica / Radiol Med. 2005 Nov-Dec;110(5-6):532-43.
2005
AOU San Luigi di Orbassano

Cardinale L; Cortese G; Borasio P; Dogliotti L; Ferraris F; Novello S; Perotto F; Scagliotti G; Fava C;

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.
2005
AOU San Luigi di Orbassano

Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;

2005
AOU San Luigi di Orbassano

Bottini A; Berruti A; Brizzi MP; Bersiga A; Generali D; Allevi G; Aguggini S; Bolsi G; Bonardi S; Tondelli B; Vana F; Tampellini M; Alquati P; Dogliotti L;

2005
AOU San Luigi di Orbassano

Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003.
2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L;

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. in British journal of cancer / Br J Cancer. 2005 Feb 28;92(4):634-8. doi: 10.1038/sj.bjc.6602335.
2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L;

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. in Journal of endocrinological investigation / J Endocrinol Invest. 2005;28(11 Suppl International):141-5.
2005
AOU San Luigi di Orbassano

Mosca A; Berruti A; Russo L; Torta M; Dogliotti L;

2004
AOU San Luigi di Orbassano

Tampellini M; Bitossi R; Brizzi MP; Saini A; Tucci M; Alabiso I; Dogliotti L;

Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2004 Feb;36 Suppl 1:S60-7. doi: 10.1016/j.dld.2003.11.021.
2004
AOU San Luigi di Orbassano

Mosca A; Dogliotti L; Berruti A; Lamberts SW; Hofland LJ;

Management of neuroendocrine differentiated breast carcinoma. in Breast (Edinburgh, Scotland) / Breast. 2004 Dec;13(6):527-9. doi: 10.1016/j.breast.2004.06.007.
2004
AOU San Luigi di Orbassano

Berruti A; Saini A; Leonardo E; Cappia S; Borasio P; Dogliotti L;

Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. in The International journal of biological markers / Int J Biol Markers. 2002 Oct-Dec;17(4):244-52. doi: 10.5301/jbm.2008.2194.
2002
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Guercio S; Torta M; Tampellini M; Dovio A; Poggio M; Scarpa RM; Angeli A;

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012.
2002
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Alquati P; De Matteis A; Nuzzo F; Giardina G; Danese S; De Lena M; Lorusso V; Farris A; Sarobba MG; DeFabiani E; Bonazzi G; Castiglione F; Bumma C; Moro G; Bruzzi P; Dogliotti L;

2002
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Terrone C; Cerutti S; Isaia G; Tarabuzzi R; Reimondo G; Mari M; Ardissone P; De Luca S; Fasolis G; Fontana D; Rossetti SR; Angeli A;

Background to and management of treatment-related bone loss in prostate cancer. in Drugs & aging / Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.
2002
AOU San Luigi di Orbassano

Berruti A; Tucci M; Terrone C; Gorzegno G; Scarpa RM; Angeli A; Dogliotti L;

Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2001 Nov-Dec;22(6):367-73. doi: 10.1159/000050639.
2001
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L;

2001
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A;

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A;

[Chronochemotherapy]. in Tumori / Tumori. 2000 May-Jun;86(3 Suppl):S32-6. doi: 10.1177/03008916000863S111.
2000
AOU San Luigi di Orbassano

Dogliotti L; Garufi C; Iacobelli S;

Circulating neuroendocrine markers in patients with prostate carcinoma. in Cancer / Cancer. 2000 Jun 1;88(11):2590-7. doi: 10.1002/1097-0142(20000601)88:11<2590::aid-cncr23>3.0.co;2-d.
2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Bellina M; Mari M; Torta M; Tarabuzzi R; Bollito E; Fontana D; Angeli A;

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Osella G; Cerutti S; Reimondo G; Martino A; Gorzegno G; Catolla R; Angeli A;

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Fasolis G; Mosca A; Tarabuzzi R; Torta M; Mari M; Fontana D; Angeli A;

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Gorzegno G; Torta M; Tampellini M; Tucci M; Cerutti S; Frezet MM; Stivanello M; Sacchetto G; Angeli A;

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.
1998
AOU San Luigi di Orbassano

Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;

Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. in The Prostate / Prostate. 1997 Dec 1;33(4):252-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<252::aid-pros5>3.0.co;2
1997
AOU San Luigi di Orbassano

Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A;

Biochemical picture of bone metabolism in breast cancer patients with bone metastases. in Anticancer research / Anticancer Res. 1995 Nov-Dec;15(6B):2871-5.
1995
AOU San Luigi di Orbassano

Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A;

Cytotoxic chemotherapy for adrenocortical carcinoma. in Minerva endocrinologica / Minerva Endocrinol. 1995 Mar;20(1):105-9.
1995
AOU San Luigi di Orbassano

Dogliotti L; Berruti A; Pia A; Paccotti P; Alì A; Angeli A;

Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. in Tumori / Tumori. 1995 Jul-Aug;81(4):299-301. doi: 10.1177/030089169508100417.
1995
AOU San Luigi di Orbassano

Berruti A; Pazè E; Fara E; Gorzegno G; Dogliotti L;

1995
AOU San Luigi di Orbassano

Berruti A; Gerbino A; Faggiuolo R; Rovero E; Dogliotti L;

Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study. in American journal of clinical oncology / Am J Clin Oncol. 1995 Feb;18(1):78-82. doi: 10.1097/00000421-199502000-00017.
1995
AOU San Luigi di Orbassano

Dogliotti L; Bertetto O; Berruti A; Clerico M; Fanchini L; Sicora W; Faggiuolo R;

Serum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone metastases. in The International journal of biological markers / Int J Biol Markers. 1994 Oct-Dec;9(4):243-6. doi: 10.1177/172460089400900407.
1994
AOU San Luigi di Orbassano

Piovesan A; Berruti A; Osella G; Raucci CA; Torta M; Dogliotti L; Angeli A;

1993
AOU San Luigi di Orbassano

Berruti A; Osella G; Raucci CA; Roncari A; Dogliotti L;

1992
AOU San Luigi di Orbassano

Berruti A; Gorzegno G; Vitetta G; Tampellini M; Dogliotti L;

Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. in Drugs / Drugs. 1992;43 Suppl 3:6-10. doi: 10.2165/00003495-199200433-00004.
1992
AOU San Luigi di Orbassano

Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte